Cora N Sternberg Selected Research

sacituzumab govitecan

4/2024	A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer.
1/2024	Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3.
12/2021	Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease.
1/2021	TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cora N Sternberg Research Topics

Disease

126	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 08/2002
86	Neoplasms (Cancer) 04/2024 - 06/2003
53	Renal Cell Carcinoma (Grawitz Tumor) 04/2023 - 06/2003
46	Carcinoma (Carcinomatosis) 09/2023 - 02/2002
36	Neoplasm Metastasis (Metastasis) 06/2023 - 10/2002
35	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024 - 01/2002
21	Disease Progression 09/2023 - 08/2002
15	Pain (Aches) 07/2022 - 11/2005
12	Fatigue 01/2022 - 03/2011
10	Hypertension (High Blood Pressure) 08/2019 - 03/2011
7	Transitional Cell Carcinoma 09/2010 - 02/2002
6	Urologic Neoplasms (Urological Cancer) 06/2023 - 07/2010
6	Neutropenia 01/2022 - 06/2009
5	Diarrhea 01/2022 - 09/2012
5	Kidney Neoplasms (Kidney Cancer) 11/2018 - 06/2003
3	Circulating Neoplastic Cells 11/2023 - 12/2016
3	Bone Diseases (Bone Disease) 01/2018 - 12/2009
3	Clear-cell metastatic renal cell carcinoma 06/2015 - 08/2013
2	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 01/2021
2	Microsatellite Instability 11/2021 - 01/2021
2	Pneumonia (Pneumonitis) 10/2021 - 04/2015

Drug/Important Bio-Agent (IBA)

38	Docetaxel (Taxotere)FDA Link 04/2024 - 01/2004
36	enzalutamideIBA 09/2023 - 05/2012
30	PlatinumIBA 04/2024 - 08/2002
29	AndrogensIBA 04/2024 - 02/2007
28	Hormones (Hormone)IBA 04/2024 - 08/2002
26	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 09/2002
24	pazopanib FDA Link 04/2023 - 02/2008
22	Prostate-Specific Antigen (Semenogelase)IBA 04/2024 - 12/2008
14	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 09/2012
13	abirateroneIBA 01/2023 - 05/2011
13	Prednisone (Sone)FDA LinkGeneric 01/2023 - 09/2009
12	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2019
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2010
12	Sunitinib (Sutent)FDA Link 12/2021 - 02/2008
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2019 - 02/2005
10	Abiraterone AcetateIBA 08/2019 - 05/2011
9	Tyrosine Kinase InhibitorsIBA 01/2021 - 02/2008
8	Gemcitabine FDA Link 01/2020 - 06/2003
7	pembrolizumabIBA 01/2024 - 01/2017
7	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 01/2020
7	avelumabIBA 09/2023 - 01/2020
7	Radium-223IBA 06/2023 - 05/2012
7	Sorafenib (BAY 43-9006)FDA Link 11/2018 - 02/2008
6	atezolizumabIBA 06/2023 - 01/2019
6	CytokinesIBA 04/2023 - 09/2009
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
5	darolutamideIBA 04/2024 - 01/2022
5	Hemoglobins (Hemoglobin)IBA 06/2023 - 04/2013
5	taxaneIBA 01/2023 - 02/2007
5	LigandsIBA 01/2022 - 02/2014
5	Angiogenesis InhibitorsIBA 12/2021 - 03/2010
5	cabazitaxel FDA Link 10/2021 - 05/2012
5	Denosumab FDA Link 01/2019 - 05/2011
5	satraplatin (JM 216)IBA 01/2012 - 11/2005
4	sacituzumab govitecanIBA 04/2024 - 01/2021
4	RamucirumabIBA 01/2022 - 11/2017
4	Everolimus FDA Link 03/2019 - 07/2016
4	Vinblastine (Vinblastine Sulfate)FDA Link 01/2018 - 09/2002
4	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 09/2002
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 06/2003
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 09/2002
3	AntigensIBA 11/2023 - 01/2022
3	Testosterone (Sustanon)FDA Link 09/2023 - 03/2008
3	Alkaline PhosphataseIBA 01/2023 - 11/2013
3	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 12/2020
3	rucaparibIBA 12/2021 - 11/2020
3	Carboplatin (JM8)FDA LinkGeneric 06/2021 - 01/2018
3	NivolumabIBA 01/2019 - 01/2019
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2018 - 03/2011
3	Diphosphonates (Bisphosphonates)IBA 07/2018 - 02/2007
3	Zoledronic Acid (Zometa)FDA Link 01/2016 - 05/2011
3	Proteins (Proteins, Gene)FDA Link 09/2012 - 03/2010
3	VaccinesIBA 05/2011 - 03/2010
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2023 - 01/2021
2	Radioisotopes (Radionuclides)IBA 10/2023 - 11/2005
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2023 - 10/2021
2	SolutionsIBA 01/2023 - 11/2021
2	ipatasertibIBA 01/2023 - 10/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022 - 01/2019
2	Monoclonal AntibodiesIBA 01/2022 - 01/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2022
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2022
2	Cell-Free Nucleic AcidsIBA 11/2021 - 12/2016

Therapy/Procedure

121	Therapeutics 04/2024 - 02/2002
99	Castration 04/2024 - 03/2008
93	Drug Therapy (Chemotherapy) 04/2024 - 08/2002
15	Combination Drug Therapy (Combination Chemotherapy) 12/2021 - 06/2003
15	Cystectomy 01/2021 - 02/2002
11	Immunotherapy 06/2023 - 02/2002
11	Adjuvant Chemotherapy 12/2020 - 12/2005
11	Neoadjuvant Therapy 10/2020 - 04/2003
6	Aftercare (After-Treatment) 09/2023 - 01/2017
6	Nephrectomy 01/2021 - 07/2010
5	Radiotherapy 08/2023 - 01/2007
4	Palliative Care (Palliative Therapy) 01/2012 - 10/2008
3	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 01/2015
3	Molecular Targeted Therapy 01/2018 - 08/2002
3	Prostatectomy (Retropubic Prostatectomy) 10/2013 - 08/2002
2	Precision Medicine 01/2022 - 02/2017